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ABSTRACT
Babelomics has been running for more than one
decade offering a user-friendly interface for the func-
tional analysis of gene expression and genomic data.
Here we present its fifth release, which includes sup-
port for Next Generation Sequencing data including
gene expression (RNA-seq), exome or genome re-
sequencing. Babelomics has simplified its interface,
being now more intuitive. Improved visualization op-
tions, such as a genome viewer as well as an inter-
active network viewer, have been implemented. New
technical enhancements at both, client and server
sides, makes the user experience faster and more
dynamic. Babelomics offers user-friendly access to
a full range of methods that cover: (i) primary data
analysis, (ii) a variety of tests for different experimen-
tal designs and (iii) different enrichment and network
analysis algorithms for the interpretation of the re-
sults of such tests in the proper functional context.
In addition to the public server, local copies of Babe-
lomics can be downloaded and installed. Babelomics
is freely available at: http://www.babelomics.org.
INTRODUCTION
Babelomics is an integrative web-based platform for the
functional analysis of transcriptomic and genomic data.
Named after the tale ‘The Babel library’ (1), a master-
piece by the famous Argentinean writer Jorge Luı´s Borges
that describes an infinite library containing all the possible
books, Babelomics has been running formore than 10 years,
becoming rapidly a classic in the field of functional analy-
sis. Its first version, published in 2005 (2), consisted of a col-
lection of methods for functional enrichment analysis (3,4)
based on different biologically relevant terms (GO; Gene
Ontology, KEGG, etc.). Since then, Babelomics has re-
leased new versions that incorporated transcriptomics pri-
mary data analysis methods from the GEPAS (5–9) (a web
tool discontinued by the end of 2012). The functionality
of these new versions was complemented with more func-
tional analyses, such as network analysis (10,11), or text-
mining (12). Also, the possible data types were expanded to
single nucleotide polymorphisms (SNPs) and thus Genome
Wide Association Analysis (GWAS) could be carried out in
Babelomics (13–15). In terms of software, Babelomics has
evolved by adopting increasingly efficient web technologies.
Thus, from the plain HTML of the initial versions (2,14),
Babelomics was re-engineered to use SOAP web services
andWeb 2.0 technology features, such as AJAX in the 2008
release (13). Later, in the 2010 release (15), the backend
was rewritten in Java while an extensive use of JavaScript at
the client side was made. The continuous adoption of new
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technologies, such as the HTML5 standard and RESTful
web services, has enabled the design of successive interfaces
that allow asynchronous use, as well as the management of
projects, jobs and user accounts.
Babelomics provides easy-to-use solutions for the most
common scenarios of genomic and transcriptomics data
analysis, offering the possibility of exploring the effects of
alteration in gene expression levels or changes in genes
sequences within a functional context (GO classes, inter-
actome, etc.) Typical Babelomics users are laboratory re-
searchers with no programming skills but have a hypoth-
esis they want to test using their data. The use of Babe-
lomics accelerates the discovery process in the laboratories
and reduces the routine work load in the bioinformatics
and biostatistics facilities thus contributing to the optimiza-
tion of the whole research ‘ecosystem’. Babelomics has also
been extensively used in courses. Currently, an average of
more than 200 experiments per day are analysed in Babe-
lomics, (http://bioinfo.cipf.es/webstats/babelomics/awstats.
babelomics.bioinfo.cipf.es.html), distributed across many
different countries (http://bioinfo.cipf.es/toolsusage). The
four Babelomics publications have received a total of 522
citations (recorded by 21 January 2015, according to Thom-
sonReuters’Web of Science, https://webofknowledge.com).
As a response to the changes in the technologies this new
version of Babelomics includes the possibility of analysing
genomic and transcriptomics data from new generation se-
quencing (NGS) experiments. Thus, in addition to conven-
tional microarray data, RNA-seq data and massive rese-
quencing data can now be uploaded and analysed. A de-
tailed analysis of use during the last four years has been
used for discontinuing a number of options that have been
scarcely used. This has resulted in a simplified, more intu-
itive and more sustainable interface for Babelomics. New
advanced options for visualization have been implemented.
These include a network viewer for the representation of the
results of network analysis, which allows users to customize
the results and to produce high quality figures for papers.
Also a genome browser, Genome Maps (16), which allows
visualizing SNPs or variants in their genomic context, was
included.
On the other hand, huge datasets from high-throughput
technologies bring about new challenges for data analysis
and visualization. To keep pace with this data revolution
Babelomics web interface has been redesigned and rewritten
using newweb technologies. Also a radical restructuring has
been done at the server side to speed it up and make the
analysis faster and more efficient.
We have reduced the dependence on many external
databases, which made the update of the relevant infor-
mation difficult in previous versions. Babelomics now uses
CellBase (17) as unique source of information. CellBase
currently resides at the European Bioinformatics Institute
(EBI) and it is updated on regular basis.
Summarizing, Babelomics 5.0 includes support for new
genomic data from NGS experiments and new analysis op-
tions. From a technological point of view it includes new vi-
sual and web technologies that provide a more robust, fast
and interactive interface.
BABELOMICS STRUCTURE
Babelomics is structured in four conceptually different parts
represented in the main menu: Processing, Expression, Ge-
nomics, Cancer and Functional. In addition, the menu bar
contains the data entry point,Upload, the Jobsmanager and
the question mark icon that contains the tutorial, contact
and credits.
Babelomics relies on a series of powerful resources de-
veloped by us in the last years. Now, CellBase (17) pro-
vides all the functional information required in the differ-
ent steps of analysis via highly optimized RESTful web
services (see https://github.com/opencb/cellbase/wiki). In-
novative visualization interfaces have been implemented
in Babelomics. An interactive and highly efficient genome
browser, Genome Maps (16), allows representing variants
(or any other genomic feature) in its genomic context.
Network analysis results are now visualized in a new in-
teractive visual framework, CellMaps (https://github.com/
opencb/cell-maps/wik), which can produce high-quality fig-
ures customized by the user.
Data upload and WorkSpace
Babelomics can be used either in anonymous mode or as a
registered user. In anonymous mode, all the uploaded data
and the results obtained (but not saved in the user’s termi-
nal) are lost at the end of the session. In registered user
mode the options are the same, the only difference is that
registered users can maintain the data and the results in the
Babelomics workspace with a limit of 10 GB (that can be
changed in local installations of Babelomics). Registration
is free. The workspace structure has improved with respect
to previous versions and has the familiar appearance and
functionality of the typical file system. The upload option
of the main menu brings about the WorkSpace, where data
files can be uploaded. Data files can also be uploaded from
within any analysis option of the menu. Different analysis
options in the menu can have specific format requirements.
As a general rule, data consist on raw sequencing (VCF or
counts) ormicroarray (.CEL, etc.) files in the first steps (Pre-
processing). In subsequent analysis steps, the files are taken
properly formatted from the previous steps. Nevertheless,
files can be preprocessed and analysed with other tools and
uploaded at later analysis steps providing they are properly
formatted.
Data processing
Microarray normalization contains the same options
that Babelomics 4 offered, which includes support for
Affymetrix normalization and both, one-channel and two-
channel normalization for Agilent and Genepix.
Regarding RNA-seq normalization, we have included an
automatic decision rule to suggest the most suitable nor-
malization method, depending on the potential biases de-
tected in the data. Themain factors that can originate biases
are: library depth (irrelevant for samples from the same li-
brary), gene length and extreme differences inmRNAabun-
dances. Thus, if a clearmRNAcomposition bias is detected,
Trimmed Means of M-values (TMM) normalization (18) is
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recommended, otherwise Reads Per Kilobase per Million
(RPKM) method (19) is preferable. Noiseq (20) is used to
carry out bias detection and the result produces the pre-
selection of the normalization method (that obviously can
be changed by the user).
In addition, there is an improved option for attribute edi-
tion that allows editing variable and label names in the data.
Another option allows several transformations over the
data matrices (including normalization, logarithm transfor-
mation, missing value imputation, etc.)
Expression data analysis
Typical expression data analyses include unsupervised anal-
ysis (clustering) and supervised analysis (differential expres-
sion or classifiers). These microarray data analyses are the
same as in Babelomics 4. Actually, previous Babelomics ver-
sions implemented new clustering methods especially de-
vised for clustering large datasets, such as the SOTA (21)
and pioneered the implementation of classifiers in web tools
(22).
The supervised analyses can be carried outwithRNA-seq
data as well. The method used for differential expression in
RNA-seq data is different from the tests used for microar-
rays, given the different statistical distributions followed by
both data types. RNA-seq counts are transformed with the
Voom method (23) that allows subsequent linear analysis
using limma (24). As in the case of microarray differential
expression tests, different multiple-test correction methods
are available.
Genomic data analysis
This module aims to give support to simple case/control
or transmission disequilibrium test (TDT) experiments in
Genome Wide Association Studies (GWAS) in Babelomics
4. The popular PLINK software (25) is used to carry out
the tests. The results include a Manhattan plot, a list of
SNPs and, below, a new graphical interface, provided by
an embedded version of the genome viewer Genome Maps
(16), that allows exploring significant SNPs or variants in
its genomics context. In this new version we have also in-
cluded one extensively used burden test for the analysis of
sequence data, the Combined Multivariate and Collapsing
(CMC) method (26). In particular, the regions defined here
are genes (given that the most common NGS data is still
produced by exome sequencing), that can be further anal-
ysed in the Functional data analysis module.
Cancer
In the last years, cancer genomics has experienced a
data generation revolution. The completion of two large
international initiatives, the Cancer Genome Atlas (27)
(http://cancergenome.nih.gov/) and the International Can-
cer Genome Consortium (28) (https://icgc.org/) has made
available a huge amount of genomic data. Thus, whole ex-
ome and genome sequencing of cancer samples is becom-
ing mainstream. Here we have integrated two popular tools
specifically devised for the analysis of cancer genomic se-
quences. One of them is Oncodrive-FM (29), which com-
putes a metric of functional impact using three well-known
methods, SIFT (30), PolyPhen (31) and MutationAssessor
(32). This metric is used to detect potential cancer driver
genes by studying how the functional impact of variants
found across several tumour samples deviates from a null
distribution. The other tool, OncodriveCLUST (33), aims
to identify genes undergoing mutations that tend to be clus-
tered instead of being evenly distributed within them. This
method is designed to exploit the observation that muta-
tions in cancer genes, especially oncogenes, often cluster in
particular positions of the protein. Both methods allow de-
tecting genes of potential relevance in cancer, within variant
files (in VCF format), which can be further analysed in its
functional context in the Functional data analysis module.
Functional data analysis
The differential aspect of Babelomics with respect to other
similar tools is that any result in terms of (often not very
informative) lists of genes with P-values obtained in any
of the analysis modules above described (Expression, Ge-
nomics andCancer) can internally be submitted to the Func-
tional data analysis module where they can be interpreted
within different functional contexts. A simple way to as-
sess the possible functional roles played by a list of genes
consists on studying the distribution of functional anno-
tations associated to these genes. GO (34) is the most ex-
tensively used source of functional annotations for genes.
Single Enrichment methods study over-representations on
any of these GO terms in the resulting lists obtained in pre-
vious analysis modules (e.g. differentially expressed genes,
genes containing SNPs or variants associated to the disease,
etc.) The popular FatiGO algorithm (3), already present
in early Babelomics versions, implements the single enrich-
ment method also in this release. Similarly, theGene Set En-
richment algorithm, now common to both, Expression (4)
and Genomic (35) data, is included in the new Babelomics
as well. In a similar way, lists of genes can be interpreted
in the context of the interactome. Thus, Network Enrich-
ment analysis finds the largest significant network that can
be formed with the genes contained in a list (10). On the
other hand, Gene set network enrichment analysis uses an
ordered list of genes to find the network significantly asso-
ciated to the highest values of the list (typically the lowestP-
values of a test from any of the analysis modules) (11). Gene
Set Enrichment methods are known to be more sensitive
than Single Enrichment methods (36,37). At present, eight
species representative of the main organismmodels are sup-
ported: Homo sapiens, Mus musculus, Rattus norvegicus,
Danio rerio, Drosophila melanogaster, Caenorhabditis ele-
gans, Arabidopsis thaliana and Saccharomyces cerevisiae.
More species will be supported in the future, although users
can upload their own annotations for other species.
A new visual framework, CellMaps (https://github.com/
opencb/cell-maps/wik), is provided in this new Babelomics
version. This framework provides a smart and interactive
representation of the resulting networks that allows users
to produce customized high-quality figures, ready for the
publisher.
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BEHIND THE SCENE: THE BABELOMICS SERVER
AND THE CLIENT
On the server side, some algorithms have been rewritten
in C/C++ in order to take now advantage of the mod-
ern multi-core CPU capabilities of the hardware in which
Babelomics runs. Also, the results of some analysis have
been indexed to speed up queries from the web site. On-fly-
time GZIP conversion has also improved data transfer for
both downloads and uploads. Web services have been re-
implemented using RESTful web services, which are lighter
and have a low latency. CellBase (17), the database where
Babelomics extracts information from, has been redesigned
and transformed into a NoSQL database. This provides a
high-performance and scalable solution to cope with in-
creasingly complex and bigger queries. CellBase was orig-
inally born as an internal relational database to store bio-
logical data for Babelomics and was later released as inde-
pendent project (17). During the last year, Babelomics and
EBI developers haveworked together tomigrate CellBase to
MongoDB, one of the most successful NoSQL databases.
MongoDB is a high-performance and scalable document-
oriented database, that makes easy to add big and complex
data and provides a rich API to execute complex queries.
The client has been completely rewritten using new tech-
nologies and standards. Babelomics is now entirely im-
plemented in HTML5 and makes use of other technolo-
gies such as Scalable Vector Graphics (SVG) for visual-
ization or IndexedDB for caching information and mini-
mizing the queries to the server. As part of this effort Ba-
belomics has significantly contributed to develop Genome
Maps and CellMaps, which have been integrated to offer
high quality visualization capabilities to Babelomics users.
Also, new Web Components standard is being used now.
This allows the community to reuse most of the visual com-
ponents developed. Due to the intensive use of cutting-edge
web technologies only modern web browsers are fully sup-
ported, these include Chrome 36+, Firefox 36+, Safari 8+
and Opera 24+.
Apart from using the public version of Babelomics, the
code is open and freely available for local installation.
The code can be found in GitHub: https://github.com/
babelomics/babelomics.
FUTURE PROSPECTS
The roadmap of Babelomics for the near future includes:
more conventional tests for relatively common experimen-
tal designs not fully covered in this version, more context
for the functional analysis and full integrative analysis of
data and information. An obvious step ahead in functional
analysis will be the inclusion of pathway analysis. We are
working on the integration of models of signalling path-
ways (38,39) in future versions of Babelomics. Another im-
portant aspect is the regulatory information. Methods for
inferring the regulatory circuit behind a transcriptomics ex-
periment already developed (40) will also be included. Ad-
ditionally, integrative analysis of complex experimental de-
signs, in which genomic and transcriptomics data are simul-
taneously obtained, will be included. Finally, support for
more species will soon be added. Since the functional infor-
mation relies on CellBase (17), the inclusion of more species
is straightforward.
CONCLUSIONS
Babelomics has evolved again and in this fifth version it
incorporates next generation sequencing data, new analy-
sis options and new technologies at both, server and client
sides. It offers a user-friendly environment that provides a
full range of solutions which include primary data analy-
sis, followed by a bunch of test for different experimental
designs and data types and completed with the possibility
of testing the biological relevance of the results obtained
within a functional context. One of the most distinctive
features of Babelomics, the functional analysis of genomic
data, is nowadays a critical aspect in data analysis.Given the
multigenic nature of most traits, these can only be explained
as the result of complex interactions between genes (41), a
notion proposed more than a decade ago in the context of
systems biology (42). Consequently,most diseases are better
understood as failures of functional modules caused by dif-
ferent combinations ofmutated genes rather than by unique
mutation(s) in one single gene (43). The use of a Systems
Biology perspective in the analysis of genomic data is lead-
ing to new approaches in biomedical research including di-
agnostics (44), drug discovery (45), as well as pharmacol-
ogy and toxicology (46). The availability of a tool that of-
fers user-friendly solutions to most of the conventional ge-
nomic analysis problems, complemented with an advanced
functional analysis, within an environment that allows stor-
ing data and results, explains the success of Babelomics for
more than a decade.
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